Meeting
2018 ASCO Annual Meeting
Real world results of liquid biopsy in stage 3/4 solid tumors and potential ''clinical actionability."
Authors
Rebecca Christian Arend
University of Alabama at Birmingham, Birmingham, AL
Rebecca Christian Arend , Angelina Londono , Alba Martínez , Andrew Ford , Charmaine Brown , Chen-Hsiung Yeh , Nader Javadi , Glen J. Weiss
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Other Novel Agents
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2555)
DOI
10.1200/JCO.2018.36.15_suppl.2555
Abstract #
2555
Poster Bd #
381
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive analysis of targetable alterations in urachal cancer by NGS.
First Author: David Joseph Benjamin
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2019 ASCO Annual Meeting
Mutational landscapes and PD-L1 expression in non-small cell lung cancer.
First Author: Kang Zhang
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock